TCL Archive ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk August 2, 1991
TCL Archive FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote December 11, 1987
TCL Archive DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year May 12, 1978